Phase 2 Type 2 Diabetes Trial Rosenstock et al., The Lancet (2023) Rosenstock and colleagues conducted a phase 2, randomized, double-blind, double-dummy, placebo-controlled and active-comparator-controlled, parallel-group trial of retatrutide in adults with type 2 diabetes
Am J Physiol Heart Circ Physiol 2019;316(1):H61-9
Imagine this: before you start a GLP-1 drug, your doctor could run a genetic test and give you realistic expectations
Barbell Medicine Coaching pairs you with a physician-led team that can coordinate with your prescriber, design your training, and adjust your nutrition to match the medications appetite effects
Investigative efforts so far concerning enterotypes, such as alpha diversity, the Firmicutes-to-Bacteroidetes ratio, aim at the identification of an MDD-specific fecal signature (Valles-Colomer et al., 2019)